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Summary Twenty-one identical tumour specimens were cultured both in the Plasma-Clot Diffusion Chamber
(PCDC) Technique and the Human Tumour Colony-forming Assay (HTCA). The culture results achieved in
the PCDC-technique were clearly superior to the HTCA: in the PCDC the mean and median plating
efficiency (PE) was 0.156 and 0.147, in the HTCA 0.103 and 0.028%; adequate growth rate in the PCDC-
technique was 67% and in the HTCA 38%. Fewer cells were required for plating in the PCDC-technique:
6.4 x 104 vs. 2.6 x 105 in the HTCA. The mean and median coefficient of variation of the colony numbers in
the PCDC-technique appeared much higher: 27.3 and 37.3 vs. 11.2 and 11.1% in the HTCA. The relation
between the PEs obtained for the same specimen in the two techniques was compared. No positive correlation
was found, which can possibly be ascribed to technical shortcomings in both techniques.
Much attention has been focused on the culture of
human tumours in in vivo and in vitro assays. These
assays are used for drug screening and sensitivity
testing of tumours of individual patients. Experi-
ments with tumour cell lines support the hypothesis
that colony formation is the most significant end
point for measuring the effect of drugs on tumour
cells (Roper & Drewinko, 1976; Rupniak et al.,
1983). The in vitro double layer soft-agar colony-
forming assay, applied to fresh human tumours,
proved promising after the first report of
Hamburger & Salmon (1977). However, wider
application of this technique has been hampered by
many limitations, which subsequently became
apparent in different studies (Selby et al., 1983).
Smith et al. (1976) described an in vivo colony-
forming technique using diffusion chambers
implanted in mice, which seemed appropriate for
the study of solid tumours. This technique has
recently been modified to improve cytology of the
cultured colonies (Willemze et al., 1985). In this
paper we report a comparative study in which
samples of identical human tumours were cultured
both in vitro and in the in vivo colony-forming
technique.
treatment (incubation for at least 2h with 0.6%
collagenase type IA and 0.002% DNAse type I -
Sigma Chemical Company, St Louis, Mo., USA -
at 37°C under continuous mechanical agitation).
Cell suspensions were subsequently passed through
21, 23 and 25 gauge needles to eliminate cellular
aggregates. Cell suspensions containing cell ag-
gregates were not used. All specimens were cultured
within 24h after removal from the patients.
Soft-agar colony-forming assay
The standard technique, as described by Hamburger
& Salmon (1977), was used except that DEAE-
dextran, 2-mercaptoethanol, CaC12 and conditioned
medium were omitted from the media and 25%
cell-free ascites fluid was added per agar layer. For
all specimens the same batch of ascites fluid was
used which had stimulated colony growth of human
ovarian cancer cell lines. The number of plated cells
varied from 1 x 105-1 x 106. The dishes were kept in
a humidified incubator with 5% carbon dioxide in
air at 37°C for 14-21 days until maximal growth was





obtained from 21 patients.




Plasma-clot diffusion chamber (PCDC) technique
Diffusion chambers were made by glueing 0.20,um
pore size, 13 mm micropore filters to one side of
plastic rings and 0.20gm nucleopore filters to the
other side of the rings. Chambers were loaded with
0.1 ml cell suspension (usually 5-x 104 cells/PCDC)
and 0.05ml citrated AB plasma (Willemze et al.
1985). Filled chambers were kept in Hank's
balanced salt solution (HBSS) at 37°C for more
than 15min until clotting occurred within the
chamber. At this moment some chambers were
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harvested to investigate the distribution of cells
within the chambers. When the distribution of cells
within these chambers appeared homogeneous and
no more than 10 aggregates defined as groups of
more than 10 cells were present, a similar single cell
suspension was assumed to be present in the other
implanted chambers. Under general anaesthesia two
chambers were implanted in the peritoneal cavity of
female, 2-3 months old, previously irradiated (8Gy)
NMRI mice. The culture time was 14-21 days;
chambers were harvested every 7-10 days, as the
mice did not survive longer after the irradiation,
and re-implanted in new irradiated mice. After
fixation and staining of the diffusion chambers as
described below, colonies were counted under a
binocular microscope.
Growth characteristics
In both techniques the single cell distribution was
confirmed by a day 1 inspection to ascertain true
colony growth. For the HTCA all dishes were
routinely inspected on day 1, for the PCDC two or
three chambers per tumour specimen were
harvested and inspected. One specimen containing
more than 10 aggregates per dish on day 1 was not
included in this comparative study. For both
techniques the same growth criteria were applied.
Colonies were defined as aggregates of >30 cells.
Growth was considered 'adequate', when >30
colonies were present in dishes or chambers apart
from the PE. Plating efficiency (PE) is defined as
number of colonies per 100 cells plated or inocula-
ted and expressed as a percentage.
Morphology ofcolonies
In vitro colony-forming assay (HTCA): The
colony-containing plate was fixed with a solution of
3% glutaraldehyde in HBSS. After the plating layer
was separated from the feeder layer, it was poured
gently onto a microscope slide. For even evapora-
tion a prewetted cellulose acetate membrane was
placed on top of the layer. Finally the standard
Papanicolaou staining technique was applied
(Salmon & Buick, 1979). Another method was to
pick individual colonies from the agar with a
micropipette followed by deposition on microscope
slides. Fixation was carried out with a polyethylene
glycol solution followed by a Papanicolaou
staining.
In vivo colony-forming assay (PCDC): Diffusion
chambers with a nucleopore membrane on one side
and a microporous membrane on the other side
were placed in a diffusion chamber holder and
incubated for 60min in a solution of 5% Ficoll
(Pharmacia) and 0.5% pronase (Calbiochem, La
Jolla, Ca, USA) in HBSS. The diffusion chamber
holder was centrifuged to sediment all colonies onto
the microporous membrane. Then the membrane
was fixed in Bouin's solution and stained with
giemsa or haematoxylin and eosin (Willemze et al.,
1985).
Results
Fresh tumour tissue, obtained from 21 patients, (17
effusions and 4 solid specimens) was cultured using
both assays. Seventeen of the tumours were derived
from patients with ovarian cancer, two from breast
cancers, one small cell lung cancer and one rhabdo-
myosarcoma. The main characteristics of all
tumour specimens (with respect to tumour type,
mean number of colonies + standard deviation and
PE) are given in Table I.
The number of colonies in the HTCA reached a
maximum after 14-21 days, as could be observed
by regular inspection. Colonies in the PCDCs could
be detected after 7 days culturing, and an increase
in number and size subsequently was observed
according to a fairly constant growth pattern.
Between days 14 and 21 the size as distinct from
the number of colonies was usually increased. The
HTCA resulted in adequate growth in 38% (8/21)
of the specimens and the PCDC-technique in 67%
(14/21). Six specimens gave rise to growth of <30
colonies per dish or chamber in both assays. Three
tumours with adequate growth in both assays had
a lower PE in the PCDC-technique than in the
HTCA, whereas five tumours resulted in a higher
PE in the PCDC-technique than in the HTCA.
Seven specimens with <30 colonies per dish in the
HTCA resulted in adequate growth and also a
significantly higher PE in the PCDC-technique.
Summarising the culture results, the mean and
median PE in the 8 specimens with adequate
growth in the HTCA was 0.103 and 0.028 (range,
0.010-0.496%). In the 14 specimens with adequate
growth in the PCDC-technique the mean median
PE was 0.156 and 0.147 (range, 0.051-0.450%). The
mean number of plated cells in the HTCA was
2.6 x105 (n 8); for the PCDC-technique this was
6.4x 104 (n 14). In the HTCA the number of
colonies ranges from 31-892 per dish, the mean and
median being 223 and 48 respectively. In the
PCDC-technique the number of colonies ranged
from 33-450 per chamber, the mean and median
being 101 and 72 respectively. The PEs are shown
in Figure 1 for all specimens with adequate growth
in at least one assay: six specimens resulted in
adequate growth by both techniques, whereas 10
specimens resulted in adequate growth by only one
technique. The culture results obtained with theIN VITRO & IN VIVO TUMOUR COLONY-FORMING ASSAY 715
Table I Culture results for identical tumour specimens in the
HTCA (in vitro colony-forming assay) (A) and the PCDC (in
vivo colony-forming assay) (B)
In vitro colony- In vivo colony-
forming assay (A) forming assay (B)
Colonies Colonies Ratio
Number +s.d. PE +s.d. PE B/A
1 SoV 42+ 0.7a 0.021 43 + Oa 0.143 6.8
2 Eov 21+ 5.7 0.007 51 + 30.7a 0.051 7.3
3 Eov 6+ 0.7 0.002 33.5+ 12.3a 0.034 17
4 Eov 41+ 4.3a 0.014 88 + 32.8a 0.176 12.6
5 Ebr 2 0.002 450 +152a 0.450 225
6 Eov 31+ 5.7a 0.010 2 + 2 0.001 0.1
7 Eov 1+ 0.7 0.001 171 + 29.3a 0.171 171
8 Eov 8+ 4.9 0.002 0
9 SoV 6+ 2.1 0.003 39a 0.078 26
10 Ssclc 2 0.000 19 + 4.9 0.019
11 Eov 892+ 14.6a 0.496 20 + 4.2 0.040 0.08
12 Srhab 267+61a 0.134 36 +
I1.9a 0.072 0.5
13 Eov 0 24 + 4.6 0.048
14 Eov 22+ 5.7 0.005 8 + 3.4 0.016 3.2
15 Ebr 10+ 2 0.002 19 + 12.7 0.038 19
16 Eov 26+ 7.0 0.009 76 + 20.2a 0.150 16.7
17 Eov 0 132 + 34.8a 0.260
18 Eov 425+41.2a 0.106 93 + 2.7a 0.186 1.8
19 Eov 53+ 7.0a 0.035 97 + 45.7a 0.194 5.5
20 Eov 35+ 4.1a 0.011 67 + 51 0.134 12.2
21 Eov 0 43 + 3.6a 0.086
ov=ovarian cancer; br=breast; sclc=small cell lung cancer;
rhabd=rhabdomyosarcoma; s.d.=standard deviation in absolute
numbers; ratio B/A=ratio between PE obtained with PCDC and
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Figure 1 PEs are given for identical specimens with
adequate growth in one or both techniques 0 =PE for
a specimen with adequate growth in only one
technique; * =PE for a specimen with adequate
growth in both techniques.
PCDC-techniques are clearly superior. Differences
in culture results between solid specimens and
effusions cannot be given, as only 4 solid specimens
and 17 effusions were cultured in both assays.
Although identical tumour material was cultured
in both assays, no correlation can be given for the
PEs achieved in the HTCA and the PCDC
techniques.
Variability within two assays
Plating in both techniques was carried out at least
in duplicate, the number of experiments ranging
from 2 to 11. Specimens with adequate growth were
plated at least in triplicate. The coefficient of
variation (CV) of the mean of the colony number
in the HTCA varied from 1.7 to 22.8%, whereas
the mean and median CV were 11.2 and 11.1%
respectively. The CV in the PCDC-technique varied
from 0 to 60.2%, whereas the mean and median
CV were 27.3 and 37.3% respectively.
Morphology ofthe colonies
The morphology of the colonies in both assays was
studied to confirm that they were derived from
tumour cells. For the HTCA it was almost im-
possible to compare the morphological charac-716 P.H.Th.J. SLEE et al.
teristics of the colonies with the histology of the
biopsy or the cytology of the effusion. The method
described by Salmon & Buick (1979) was
simple and enabled the staining of the complete
agar layer, but it was often difficult to discriminate
between individual cells in separate colonies. Above
all, the morphology was poor. Individual colonies
were also removed from the agar layer which was
an arduous task. Finally only few colonies
appeared to be stained. They still proved difficult
to compare with the morphology of the original
specimen. The morphology of the cells within the
colonies derived from the PCDC-technique was
clearly better and even enabled a distinction to be
made between different cell types within colonies.
Discussion
Since the work of Park et al. (1971) other groups
have confirmed that for experimental tumours in
vitro colony formation is the most reliable
parameter for studying lethal effects induced by
drugs (Thomson & Rauth, 1974; Roper &
Drewinko, 1976; Courtenay, 1976).
By contrast, the in vitro colony-forming assays
with fresh human tumour specimens have many
practical and theoretical problems. The plating
efficiency is low (usually one colony per 10,000
plated cells) and the number of specimens which
result in adequate growth are low: in larger studies
usually 40% (Von Hoff, 1983). Clumping of cells is
a serious difficulty for any clonogenic cell assay, so
that the descriptive term: 'colony-forming assay' is
preferred to 'tumour stem cell assay' or 'clonogenic
cell assay' (Agrez et al., 1982, Umbach et al., 1983).
The failure to grow in vitro may partly be
explained by inadequate culture conditions. Several
ways to optimize culture conditions have been
investigated: the application of a low oxygen
concentration, the replenishment of the medium at
weekly intervals, the addition of feeder cells or cell-
free ascites fluid. The addition of 25% cell-free
ascites fluid has repeatedly been found to result in
better growth by others (Uitendaal et al., 1983), as
well as ourselves (unpublished observations). Never-
theless, in vitro assays are frequently hampered
by insufficient growth. The diffusion chamber
technique may provide another way to overcome
some of these problems. Tumour cells may grow
better in the peritoneal cavity: nutrients, waste
products and presumed humoral stimulatory and
inhibitory factors can be exchanged in vivo, whereas
the implanted cells are isolated from host cells. In
this technique, tumour cell exposure to drugs is
closer to the patients situation than in in vitro
techniques.
We have compared colony growth of fresh
tumour cells in an in vivo and an in vitro colony-
forming assay. A significantly higher PE was seen
in the in vivo assay than in the slightly modified in
vitro colony-forming assay. The adequate growth
rate was twice as high for the PCDC-technique as
for the HTCA. The number of plated cells required
for plating in the PCDC-technique was only 25%
of that in the HTCA. In the PCDC-technique
smaller amounts of tumour tissue can be studied
and colony formation can be observed in specimens
which do not result in adequate colony growth in
the HTCA. A positive correlation between the PE
in the PCDC-technique and in the HTCA would
support the assumption that both techniques
culture the same cell type, viz. the colony-forming
cell. It could not be demonstrated in our material,
although numbers were limited (Figure 1).
Hitherto all groups have used agar as a semisolid
medium to immobilise the single cells in the
diffusion chambers. As the agar prevents optimal
morphology of the cultured colonies, plasma clots
were used instead (Willemze et al., 1985).
Morphology in the PCDC was of good quality and
enabled a comparison with the original histology or
cytology. With the HTCA this was not possible.
Direct comparisons of the growth of fresh
tumour cells in in vitro and in vivo colony-forming
techniques have previously been reported (Courtenay
et al., 1978, Sobrero et al., 1984). Courtenay et al.,
(1978) described an in vitro technique, which is
characterised by a low oxygen tension, rat red
blood cells as feeder layer and test tubes (instead
of Petri dishes) with a replenishable liquid phase.
Although in a minority of specimens better growth
was obtained in one or other of the assays, there
was no evidence that either of them was superior
(Courtenay et al., 1978). Sobrero et al. (1984)
compared the growth of several specimens in the
colony-forming assay according to Hamburger and
Salmon and the agar-diffusion chamber technique.
Twenty specimens resulted in 'successful' growth
in both assays. Experiments were considered
'successful', when at least 10 colonies per chamber
or dish had grown. The median PE in the in vivo
assay was more than 3 times higher than in the in
vitro assay, although the number of plated cells in
the HTCA was generally 10 times higher. Sobrero
et al. (1984) found a positive correlation between
the PE in the HTCA and the PCDC-technique for
specimens with 'successful' growth. When we
applied the same criteria as Sobrero et al. no
positive correlation could be found for specimens
with 'successful' growth (n= 10) (Figure 1 and
Table I).
The coefficient of variation per colony number
reflects the counting of cells, dilution, the growth ofIN VITRO & IN VIVO TUMOUR COLONY-FORMING ASSAY 717
colonies and the final counting of colonies per dish
or chamber. The reason for variability are partly
similar for both techniques except for the growth in
animals. The significant wider variation in colony
numbers in the PCDC-technique may therefore be
ascribed mainly to the growth in animals.
Conclusions:
The PCDC-technique appeared to have a higher PE
and a higher growth rate for fresh tumour
specimens; the number of cells inoculated in the
diffusion chambers was much lower than the
required number of cells to be plated in the HTCA.
The (near) single cell origin of the colonies was
based on inspection of all Petri dishes in the HTCA
and on inspection of two or three control chambers
in the PCDC-technique. The morphology of the
colonies in the PCDC was superior to the
morphology in the HTCA. Time and costs involved
in tumour cell culture using the two techniques are
more favourable in the HTCA than in the PCDC-
technique. The variability in the PCDC was larger
than in the HTCA possibly as a consequence of the
use of animals. Drug testing in tumour bearing
animals is closer to the patient situation than in
vitro drug testing. This is even more important for
drugs requiring metabolic activation. Further
studies are required before a final choice can be
made as to which culture technique is most ap-
propriate for a certain application.
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